title: Renovascular hypertension: is there still a role for stent revascularization?
abstract: OBJECTIVE
  Management of renovascular hypertension remains controversial and problematic, in part, due to failure of prospective trials to demonstrate added benefit to revascularization.
  
  
  RESULTS
  Effective drug therapy often can achieve satisfactory blood pressure control, although concerns persist of the potential for progressive, delayed loss of kidney function beyond a stenotic lesion. Recent studies highlight benefits of renal artery stenting in subsets of patients including those with recurrent pulmonary edema and those intolerant to blockade of the renin-angiotensin system. Occasional patients with recent deterioration in renal function recover sufficient glomerular filtration rate after stenting to avoid requirements for renal replacement therapy. Emerging paradigms from both clinical and experimental studies suggest that hypoxic injury within the kidney activates inflammatory injury pathways and microvascular rarification that may not recover after technically successful revascularization alone. Initial data suggest that additional measures to repair the kidney, including the use of cell-based therapy, may offer the potential to recover kidney function in advanced renovascular disease.
  
  
  CONCLUSIONS
  Specific patient groups benefit from renal revascularization. Nephrologists will increasingly be asked to manage complex renovascular patients, different from those in randomized trials, that require intensely individualized management.
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota 55905, USA. textor.stephen@mayo.edu
authors.forename: Stephen C
authors.initials: SC
authors.lastname: Textor
mesh_terms: D000818:Animals; D050197:Atherosclerosis / Q000150:complications; D006801:Humans; D006978:Hypertension, Renovascular / Q000188:drug therapy / Q000601:surgery*; D007674:Kidney Diseases / Q000503:physiopathology / Q000601:surgery; D012078:Renal Artery Obstruction / Q000601:surgery; D015607:Stents; D013514:Surgical Procedures, Operative; D014652:Vascular Diseases / Q000503:physiopathology / Q000601:surgery
references.citation: Dtsch Med Wochenschr. 2011 Jan;136(3):76-81
references.pmid: 21225553
references.citation: Eur Heart J. 2011 Sep;32(18):2231-5
references.pmid: 21406441
references.citation: J Vasc Surg. 2012 Feb;55(2):421-7
references.pmid: 22112553
references.citation: Eur Heart J. 2013 Feb;34(7):540-548a
references.pmid: 22771675
references.citation: Eur J Heart Fail. 2012 Jul;14(7):773-81
references.pmid: 22455866
references.citation: J Clin Hypertens (Greenwich). 2010 Jan;12(1):1-2
references.pmid: 20047621
references.citation: Mayo Clin Proc. 2011 Jul;86(7):603-5
references.pmid: 21719617
references.citation: Am Heart J. 2008 Sep;156(3):549-55
references.pmid: 18760140
references.citation: Ann Vasc Surg. 2012 Apr;26(3):434-42
references.pmid: 22305685
references.citation: J Hum Hypertens. 2012 Aug;26(8):507-16
references.pmid: 21716318
references.citation: J Am Coll Cardiol. 2011 Nov 1;58(19):2020-45
references.pmid: 21963765
references.citation: Interact Cardiovasc Thorac Surg. 2011 Feb;12(2):323-5
references.pmid: 21118836
references.citation: Clin J Am Soc Nephrol. 2013 Apr;8(4):546-53
references.pmid: 23258796
references.citation: Circ Cardiovasc Interv. 2011 Jun;4(3):213-5
references.pmid: 21673322
references.citation: Hypertension. 2011 Dec;58(6):1066-72
references.pmid: 22042812
references.citation: Cardiol Rev. 2012 Jul-Aug;20(4):189-93
references.pmid: 22314144
references.citation: Curr Opin Nephrol Hypertens. 2011 Mar;20(2):139-45
references.pmid: 21157335
references.citation: Nephrol Dial Transplant. 2013 Feb;28(2):479-83
references.pmid: 22262735
references.citation: Am Heart J. 2011 Mar;161(3):622-630.e1
references.pmid: 21392620
references.citation: Eur J Heart Fail. 2012 Jul;14(7):764-72
references.pmid: 22508558
references.citation: Circ Cardiovasc Interv. 2011 Jun;4(3):219-25
references.pmid: 21521835
references.citation: Kidney Int. 2013 Jan;83(1):28-40
references.pmid: 23151953
references.citation: J Vasc Surg. 2012 Feb;55(2):413-9; discussion 419-20
references.pmid: 22133456
references.citation: Minerva Cardioangiol. 2011 Dec;59(6):533-42
references.pmid: 22134468
references.citation: Hypertension. 2012 Nov;60(5):1242-9
references.pmid: 23045468
references.citation: Clin J Am Soc Nephrol. 2012 Feb;7(2):224-30
references.pmid: 22193234
references.citation: Nephrol Dial Transplant. 2011 Apr;26(4):1205-10
references.pmid: 20817669
references.citation: Am J Physiol Renal Physiol. 2012 Jun 1;302(11):F1455-64
references.pmid: 22378822
references.citation: Hypertension. 2010 Apr;55(4):961-6
references.pmid: 20194303
references.citation: Nephrol Dial Transplant. 2012 Apr;27(4):1403-9
references.pmid: 21993376
references.citation: Hypertens Res. 2011 Oct;34(10):1078-81
references.pmid: 21677661
references.citation: Circulation. 2009 Feb 3;119(4):547-57
references.pmid: 19153272
references.citation: Stem Cells. 2012 May;30(5):1030-41
references.pmid: 22290832
references.citation: Am J Physiol Renal Physiol. 2012 May 15;302(10):F1342-50
references.pmid: 22357917
references.citation: J Vasc Surg. 2002 Feb;35(2):236-45
references.pmid: 11854720
references.citation: Am J Physiol Renal Physiol. 2011 Jun;300(6):F1394-401
references.pmid: 21367913